Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance.
- NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_assertion description "[We used the allelic discrimination method to identify polymorphisms in GSTT1, SULT1C2, CDA, SXR (drug metabolic pathways), XPD, XPA, XPG, ERCC1, TOP2A (DNA repair), VEGF (angiogenesis), and MDR1 (multidrug resistance) genes in 110 adult patients with intermediate-risk AML, enrolled in the CETLAM-99 prospective trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance.
- NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_assertion evidence source_evidence_literature NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance.
- NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_assertion SIO_000772 16507781 NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance.
- NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_assertion wasDerivedFrom gad-20150221 NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance.
- NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_assertion wasGeneratedBy ECO_0000203 NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance.
- gad-20150221 importedOn "2015-02-21" NP99224.RAopE1ImbxOb5st2F48cA4W6sOHnr3gRt8NpRyS-SOLFU130_provenance.